6/14
07:11 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Sanford C. Bernstein from an "underperform" rating to a "market perform" rating. They now have a $44.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Sanford C. Bernstein from an "underperform" rating to a "market perform" rating. They now have a $44.00 price target on the stock.
6/14
05:54 am
ions
Rating for IONS
Low
Report
Rating for IONS
6/14
05:54 am
ions
Rating for IONS
Low
Report
Rating for IONS
6/3
08:03 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Medium
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
6/3
05:27 am
ions
Rating for IONS
Medium
Report
Rating for IONS
6/3
05:27 am
ions
Rating for IONS
Medium
Report
Rating for IONS
5/8
10:42 am
ions
Rating for IONS
Low
Report
Rating for IONS
5/8
10:42 am
ions
Rating for IONS
Low
Report
Rating for IONS
5/8
08:08 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
5/8
05:46 am
ions
Rating for IONS
Low
Report
Rating for IONS
5/8
05:46 am
ions
Rating for IONS
Low
Report
Rating for IONS
4/10
08:06 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
4/10
08:06 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
4/10
04:30 am
ions
Rating for IONS
Low
Report
Rating for IONS
4/10
04:30 am
ions
Rating for IONS
Low
Report
Rating for IONS
4/9
05:38 pm
ions
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
Low
Report
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
4/9
05:38 pm
ions
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
Low
Report
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
4/9
04:39 pm
ions
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
4/9
04:39 pm
ions
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
4/9
11:17 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
4/9
11:17 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
4/9
08:26 am
ions
Rating for IONS
Low
Report
Rating for IONS
4/9
08:26 am
ions
Rating for IONS
Low
Report
Rating for IONS
4/9
08:09 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
4/9
06:33 am
ions
Rating for IONS
Low
Report
Rating for IONS